Assessing the prevalence of bloodstream infections in a hospital setting
Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
This study looks at how common bloodstream infections are in heart patients at a hospital to help understand what causes them and how to treat them better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 1 Day and up |
| Sex | All |
| Sponsor | Port Said University Academic / other |
| Locations | 2 sites (Port Said and 1 other locations) |
| Trial ID | NCT06458231 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the prevalence of primary and secondary central line-associated bloodstream infections (CLABSI) among patients admitted to the Cardiovascular Unit at a tertiary care hospital. It involves collecting comprehensive clinical data, including medical history, symptoms, and laboratory investigations, to identify the causative microorganisms and their antibiotic sensitivity. The study will utilize automated systems for microbiological diagnosis and will classify infections based on established CDC criteria. The findings will help in understanding the epidemiology of CLABSI and the factors contributing to these infections.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with sepsis, regardless of age or sex, who are admitted to the Cardiovascular Unit.
Not a fit: Patients who have received non-beta lactam antibiotics within the past 24 hours or whose samples are contaminated will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and management strategies for bloodstream infections in hospitalized patients.
How similar studies have performed: Other studies have shown success in identifying and managing CLABSI, making this approach relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients diagnosed with sepsis based on medical history, lab investigations and clinical picture. * Both sex, and all age-groups. Exclusion Criteria: * Patients diagnosed with sepsis proved by medical history, lab investigations and clinical picture who received non-beta lactam antibiotics for the past 24 hours. * Samples proved contaminated by microbial flora will be rejected.
Where this trial is running
Port Said and 1 other locations
- Prof. Refat Sadeq — Port Said, Egypt (Recruiting)
- Faculty of Medicine Portsaid Uni — Port Said, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.